ClinVar Miner

Submissions for variant NM_012210.4(TRIM32):c.1370dup (p.Leu457fs)

dbSNP: rs35904234
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001067138 SCV001232178 pathogenic Bardet-Biedl syndrome 2019-12-31 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asp487 amino acid residue in TRIM32. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID:11822024, 21775502, 15786463). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy (Invitae). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the TRIM32 gene (p.Leu457Phefs*43). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 197 amino acids of the TRIM32 protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.